PG
GILD icon

Proffitt & Goodson’s Gilead Sciences GILD Stock Holding History

Proffitt & Goodson’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-36
Closed -$2K – 262
2020
Q4 		$2K Hold
36
– – ﹤0.01% 248
2020
Q3 		$2K Hold
36
– – ﹤0.01% 254
2020
Q2 		$3K Hold
36
– – ﹤0.01% 247
2020
Q1 		$3K Hold
36
– – ﹤0.01% 186
2019
Q4 		$2K Hold
36
– – ﹤0.01% 205
2019
Q3 		$2K Hold
36
– – ﹤0.01% 199
2019
Q2 		$2K Hold
36
– – ﹤0.01% 191
2019
Q1 		$2K Buy
+36
New +$2.39K ﹤0.01% 189

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Proffitt & Goodson's GILD Position: Q1 2021 in Review

Proffitt & Goodson sold out of Gilead Sciences (GILD) in Q1 2021, closing a stake of 36 shares — an estimated $2K sold.

Proffitt & Goodson first reported a position in GILD in Q1 2019 and held it in 8 quarters. The position peaked at $3K in Q2 2020. 1,567 funds tracked by Wall St. Rank hold GILD as of Q1 2021.

  • Proffitt & Goodson reported no remaining Gilead Sciences position as of Q1 2021 after selling out during the quarter.
  • Proffitt & Goodson sold 36 Gilead Sciences shares in Q1 2021, an estimated $2K.
  • Proffitt & Goodson first reported a position in Gilead Sciences in Q1 2019 and held it in 8 quarters.
  • Proffitt & Goodson's Gilead Sciences position peaked at $3K in Q2 2020.
  • 1,567 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2021.

Based on Proffitt & Goodson's 13F filing for Q1 2021, filed 3 May 2021.